Coronary artery spasm is a condition where the arteries that supply blood to your heart suddenly tighten, temporarily reducing or blocking blood flow. While many people experience no symptoms, these spasms can cause chest pain and increase the risk of serious heart complications. Treatment focuses on preventing future episodes and relieving symptoms through medications and lifestyle changes.

How We Approach the Treatment of Coronary Artery Spasm

When someone experiences coronary artery spasm, the main goal of treatment is to prevent future episodes and manage any chest pain that occurs. This condition can happen to anyone, though it often affects people between the ages of 40 and 70. Interestingly, many individuals with coronary artery spasms do not have the typical risk factors for heart disease, such as high cholesterol or high blood pressure, though these conditions can still play a role.^[1][3]

The treatment approach depends on several factors, including how frequently spasms occur, how severe the symptoms are, and whether the person has other heart conditions such as atherosclerosis (plaque buildup in the arteries). Since coronary artery spasms can range from mild episodes that cause no noticeable symptoms to severe contractions that completely block blood flow, doctors carefully assess each person’s situation before recommending a treatment plan.^[2]

Treatment is not one-size-fits-all. Some people need only minimal intervention, while others require multiple medications to control their symptoms. The medical team will also look at potential triggers, such as tobacco use, exposure to cold temperatures, extreme stress, or use of certain drugs like cocaine or amphetamines. Addressing these triggers is an essential part of managing the condition and preventing future spasms.^[1][2]

There are two main categories of treatment available today: standard medical therapies that have been used for many years and approved by medical societies, and newer approaches being tested in clinical research studies. Both aim to relax the coronary arteries, improve blood flow to the heart, and reduce the risk of complications such as heart attack or dangerous heart rhythms.^[7]

Standard Medical Treatment for Coronary Artery Spasm

The cornerstone of standard treatment for coronary artery spasm involves medications that help relax the coronary arteries and prevent them from tightening. These medications have been studied extensively and are recommended by major cardiology organizations.^[7][14]

Calcium Channel Blockers: The First Line of Defense

Calcium channel blockers are considered the first-line treatment for coronary artery spasm. These medications work by relaxing the smooth muscle cells in the walls of your arteries, which helps prevent the sudden contractions that cause spasms. They also help lower blood pressure and improve blood flow to the heart muscle.^[7][14]

Common calcium channel blockers used for this condition include amlodipine (sold under brand names such as Norvasc), diltiazem (Cardizem), and long-acting nifedipine (Adalat). These medications are usually taken once or twice daily, depending on the specific drug and formulation. Doctors typically start with a moderate dose and adjust it based on how well the symptoms are controlled and whether any side effects develop.^[19]

The effectiveness of calcium channel blockers has been demonstrated in numerous studies. They not only reduce the frequency of angina attacks but also improve the overall quality of life for people with coronary artery spasms. However, they can cause side effects such as swelling in the ankles, dizziness, flushing, or constipation. Most people tolerate these medications well, but it’s important to discuss any concerns with your doctor.^[7]

Nitrates for Immediate Relief and Prevention

Nitrates are another important class of medications used to treat coronary artery spasms. They work by causing blood vessels to dilate (widen), which improves blood flow to the heart. Nitrates come in different forms: some act very quickly to relieve acute symptoms, while others are long-acting and help prevent future episodes.^[1][2]

For immediate relief during a spasm, doctors prescribe nitroglycerin in forms that work within minutes, such as sublingual tablets (placed under the tongue), topical ointments, or intravenous solutions. When someone experiences chest pain from a coronary artery spasm, taking nitroglycerin can quickly stop the spasm and relieve symptoms. This medication is so effective that many people with coronary artery spasms carry nitroglycerin with them at all times.^[1][10]

Long-acting nitrates, such as isosorbide dinitrate (Isordil) or sustained-release nitroglycerin, are used to prevent spasms from occurring. These medications are taken regularly, usually once or twice a day. They help maintain a steady level of the drug in the body, which keeps the coronary arteries relaxed. Common side effects of nitrates include headaches, dizziness, and a drop in blood pressure when standing up. These side effects often lessen over time as your body adjusts to the medication.^[19]

Combining Medications for Better Control

When calcium channel blockers alone do not adequately control symptoms, doctors often add long-acting nitrates or, where available, a medication called nicorandil. This combination approach takes advantage of the different ways these drugs work to relax the coronary arteries. Calcium channel blockers and nitrates act through different mechanisms, so using them together can provide better symptom control than either medication alone.^[7][14]

Nicorandil is a medication that combines properties of both nitrates and potassium channel openers. It helps dilate coronary arteries through two different pathways, making it particularly useful for people who do not respond well to standard treatments. However, nicorandil is not available in all countries, including the United States, though it is widely used in Europe and Japan.^[14]

Additional Medications and Supportive Care

For people who also have atherosclerosis (plaque buildup in the arteries), doctors may prescribe additional medications. Statins are cholesterol-lowering drugs that have been shown to improve outcomes in patients with coronary artery spasms, particularly those who experience acute heart events. The American Heart Association and American College of Cardiology recommend high-intensity statin therapy for people with chronic coronary disease, with a goal of reducing LDL cholesterol (the “bad” cholesterol) by at least 50%.^[10]

Aspirin and other antiplatelet medications may be used to reduce the risk of blood clots, though these are more important when atherosclerosis is present. Some doctors also recommend magnesium supplements, as magnesium deficiency has been linked to increased risk of coronary artery spasms. However, more research is needed to confirm the benefits of magnesium supplementation.^[10][19]

Duration of Treatment

Treatment for coronary artery spasm is typically long-term, often lasting for years or even a lifetime. The goal is to prevent spasms from occurring and to reduce the risk of serious complications. Some people may be able to reduce their medication doses over time if their symptoms are well controlled and they have made significant lifestyle changes, such as quitting smoking. However, any changes to medication should always be done under close medical supervision.^[7]

Common Side Effects to Watch For

All medications can cause side effects, and those used to treat coronary artery spasms are no exception. Calcium channel blockers can cause ankle swelling, dizziness, flushing, constipation, and in some cases, a slower heart rate. Nitrates commonly cause headaches, especially when first starting treatment, and can cause dizziness or lightheadedness due to lowered blood pressure. If you experience severe or persistent side effects, it’s important to discuss them with your doctor rather than stopping the medication on your own, as sudden discontinuation can sometimes worsen symptoms.^[19]

Emerging Treatments Being Studied in Clinical Research

While standard treatments work well for many people, some individuals continue to have frequent or severe spasms despite optimal medical therapy. For these cases, researchers are investigating several promising new approaches and medications in clinical trials.^[7][14]

Rho-Kinase Inhibitors: A Novel Approach

One of the most promising areas of research involves medications called Rho-kinase inhibitors. These drugs target a specific enzyme pathway in the smooth muscle cells of blood vessel walls. The Rho-kinase pathway plays a key role in causing blood vessels to contract, so blocking this pathway can help prevent coronary artery spasms.^[14]

Fasudil is the most studied Rho-kinase inhibitor for coronary artery spasm. This medication has been approved in Japan for treating various vascular conditions and has shown promising results in research studies for preventing coronary spasms. Fasudil works by interfering with the cellular machinery that causes blood vessel walls to tighten. It represents a fundamentally different approach compared to calcium channel blockers or nitrates.^[14]

Clinical trials have explored fasudil’s use in people with coronary artery spasms that do not respond adequately to standard treatments. The research has focused on understanding the drug’s safety profile, determining the most effective doses, and comparing its effectiveness to conventional therapies. While results have been encouraging, fasudil is not yet widely available outside of Japan and a few other Asian countries. Researchers continue to study this medication, and it may become more broadly available in the future if ongoing trials continue to show positive results.^[14]

Anti-Adrenergic Therapies

The autonomic nervous system, which controls many automatic functions in the body, appears to play a role in triggering coronary artery spasms in some people. This has led researchers to investigate medications that modify the activity of this system, particularly drugs that affect adrenaline-related pathways.^[3][14]

Some clinical research has explored the use of anti-adrenergic drugs for people with refractory coronary artery spasms (spasms that don’t respond well to standard treatments). These medications work by blocking certain receptors that respond to stress hormones, potentially reducing the triggers that cause the coronary arteries to go into spasm. However, this approach is still experimental, and more research is needed to determine which patients might benefit most from these therapies.^[14]

Neural Therapies and Interventions

For people with severe, life-threatening coronary artery spasms that cannot be controlled with medications, some specialized centers are investigating more invasive approaches. These include procedures that modify nerve signals to the heart or procedures that physically alter the blood vessels.^[14]

Neural therapy approaches might involve procedures that affect the nerves controlling the coronary arteries. The theory is that by modifying nerve signals, doctors can reduce the likelihood of spasms occurring. However, these approaches are highly experimental and are typically only considered for patients with the most severe forms of the disease who have not responded to all available medications.^[14]

Percutaneous Coronary Interventions

Percutaneous coronary interventions are procedures performed through a catheter inserted into the blood vessels, usually through the groin or wrist. These include angioplasty (using a balloon to widen the artery) and stent placement (inserting a small tube to keep the artery open).^[14]

These procedures are well-established treatments for coronary arteries narrowed by atherosclerosis, but their role in treating coronary artery spasms is more limited and controversial. Some research has investigated whether placing stents in arteries prone to spasm can prevent future episodes. However, the results have been mixed, and there are concerns that the procedure itself might cause complications or that spasms could occur in other locations.^[14]

Percutaneous interventions are generally reserved for specific situations, such as when a coronary artery spasm occurs at the site of a significant atherosclerotic blockage. In such cases, treating the underlying blockage with angioplasty and stenting might help reduce both the blockage and the tendency for spasms to occur at that location. Clinical trials continue to explore when and in whom these procedures might be beneficial.^[14]

Device Therapy for Rhythm Complications

Some people with coronary artery spasms experience dangerous heart rhythm disturbances. These can include very fast rhythms (tachyarrhythmias) or very slow rhythms (bradyarrhythmias). In rare cases, these rhythm problems can cause fainting (syncope) or even cardiac arrest.^[7][14]

For patients at high risk of life-threatening fast heart rhythms, doctors may consider implanting an implantable cardioverter defibrillator (ICD). This is a small device placed under the skin that continuously monitors the heart rhythm and can deliver an electrical shock if a dangerous rhythm is detected. The decision to implant an ICD depends on several factors, including the risk of recurrent dangerous rhythms and how well medications are controlling the spasms.^[7][14]

Similarly, for patients who experience very slow heart rates due to coronary artery spasms affecting the parts of the heart that control rhythm, a pacemaker might be considered. A pacemaker is a device that helps maintain a steady heart rate by delivering small electrical impulses when needed. These device therapies are typically reserved for people with severe complications and are used in combination with medications to prevent spasms.^[7][14]

Research Trial Phases and Patient Eligibility

Clinical trials for coronary artery spasm treatments typically progress through several phases. Phase I trials focus primarily on safety, testing new medications or approaches in small groups of people to identify potential side effects and determine safe doses. Phase II trials examine whether the treatment actually works and continues safety monitoring in larger groups. Phase III trials compare the new treatment to standard therapies to determine if it offers advantages over existing options.^[7]

Eligibility for clinical trials varies depending on the specific study. Generally, researchers look for people who have been diagnosed with coronary artery spasms and who continue to experience symptoms despite standard treatments. Some trials accept patients from specific geographic regions, such as Europe, the United States, or Asia, where the condition may be more common or where research centers have particular expertise. If you are interested in participating in a clinical trial, discussing this option with your cardiologist is the best first step.^[3]

Most common treatment methods

• Calcium Channel Blockers
  • First-line medication that relaxes coronary artery smooth muscle to prevent spasms
  • Common examples include amlodipine, diltiazem, and long-acting nifedipine
  • Taken daily to maintain steady blood levels and prevent future episodes
  • May cause side effects such as ankle swelling, dizziness, flushing, or constipation
• Nitrates
  • Fast-acting forms (sublingual nitroglycerin) provide immediate relief during acute spasm episodes
  • Long-acting forms (isosorbide dinitrate, sustained-release nitroglycerin) prevent future spasms
  • Work by dilating blood vessels and improving blood flow to the heart
  • Common side effects include headaches, dizziness, and low blood pressure
• Combination Medication Therapy
  • Calcium channel blockers combined with long-acting nitrates for better symptom control
  • Addition of nicorandil (where available) for patients not responding to standard therapy
  • Uses different mechanisms of action to maximize artery relaxation
• Rho-Kinase Inhibitors (Experimental)
  • Fasudil targets a specific enzyme pathway involved in blood vessel constriction
  • Currently approved in Japan and being studied in clinical trials elsewhere
  • Represents a novel approach for patients with refractory spasms
• Statins and Cardiovascular Risk Management
  • Cholesterol-lowering medications that improve outcomes in patients with coronary disease
  • High-intensity statin therapy recommended by cardiology guidelines
  • May help stabilize atherosclerotic plaques that can trigger spasms
• Device Therapies
  • Implantable cardioverter defibrillators (ICDs) for patients at risk of dangerous fast heart rhythms
  • Pacemakers for patients experiencing very slow heart rates due to spasms
  • Reserved for severe cases with life-threatening rhythm complications
• Percutaneous Coronary Interventions
  • Angioplasty and stent placement in selected cases with significant atherosclerotic blockages
  • Limited role in treating pure coronary artery spasm without underlying plaque
  • Considered primarily when spasm occurs at sites of significant coronary narrowing